Clinical evaluation of cefuzonam for bacterial pneumonia
Mikasa, K.; Sawaki, M.; Konishi, M.; Kunimatsu, M.; Hamada, K.; Takeuchi, S.; Maeda, K.; Narita, N.
Japanese Journal of Antibiotics 44(2): 111-116
1991
ISSN/ISBN: 0368-2781 PMID: 2041152 Document Number: 381441
Ten patients with moderate or severe bacterial pneumonia with underlying diseases or complications were treated with cefuzonam (CZON) at a daily dose of 2 g to 4 g. The clinical effectiveness was good in 9 patients. No side effects or abnormal laboratory test results were observed in any patient. These results suggest that CZON may be useful in the treatment of bacterial pneumonia.